Every baby counts!
The following key words can also be useful to find us using internet search engines: "gns newborn", "gns neonate", "gns society", "global newborn" and "global neonatal society"
Maheshwari A, Lui K, Motta M. To save babies, we need a team – let’s build one! Newborn 2024; 3(1):TBD. DOI: 10.5005/newborn-3-1-iv.
----------------------------------------------------------------------------------------------------------------------------------------------------
Lawn JE, Ehret DEY, Mutema T, Stevenson A, Walker K, et al. Every Newborn Counts, Everywhere: Statement from the 2023 Joint European Neonatal Societies’ (jENS) Congress. Newborn 2024; 3(1):1-2. DOI: 10.5005/jp-journals-11002-0087.
Abstract: This is the statement from the Joint European Neonatal Societies’ (jENS) Congress that was held in Rome in September 2023. Each year, we lose nearly 1.9 million fetuses in stillbirths and about 2.3 million newborns. The vast majority of these deaths are recorded in the relatively-disadvantaged periequitorial and tropical countries, and most are preventable. The necessary, proven, highly-effective interventions are available but we need to work together to improve usage/access to save more babies and reach the 2030 Sustainable Development Goals (SDGs). To reach the SDG target of <12 neonatal deaths per 1000 live births, we need to invest smartly, implement sustainable programs, integrate our efforts, and innovate to improve the efficiency of these efforts.
Key scientific associations: Baby, Global health, Infant, Low- and middle-income countries, Newborn, Neonate, neonatal deaths, 2030 sustainable development goals, SDGs, Every Newborn Action Plan, Reproductive, Maternal, Newborn, and Child Health (RMNCH), invest, implement, sustainable, programs, integrate, innovate.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------
Mohan S, Badami K, Kumar P, Shilpa YD, Hemalata BC, Kavitha Tumbadi K. Prediction of Retinopathy of Prematurity in Single and Twin Babies: The Predictive Accuracy of WINROP. Newborn 2024; 3(1):3–7. DOI: 10.5005/jp-journals-11002-0084.
Key scientific associations: India, Retinopathy of prematurity, Twins, Type I ROP, WINROP, gestational age, blindness, delayed retinal vascularization, vaso-proliferation, intravitreal angiogenesis, Fibrovascular retinal detachment, oxygen level, indirect ophthalmoscopy, RetCam, prediction models, CO-ROP, ROP Score, CHOP-ROP, Early Treatment of Retinopathy of Prematurity (ETROP) cooperative group classification, WINROP alarm.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------
Sahota R, Singh V, Parveen H, Kaur N, Upreti N, et al. Comparison of Transcutaneous Bilirubin with Total Serum Bilirubin Levels Before, During, and Post-phototherapy in Preterm and Term Newborns in Uttarakhand, India. Newborn 2024; 3(1):8–12. DOI: 10.5005/jp-journals-11002-0086.
Abstract: Background: Neonatal jaundice, although generally benign, can pose a significant threat to a select number of newborns, potentially resulting in severe brain damage or even death.
Objectives: To compare the transcutaneous bilirubin (TCB) with total serum bilirubin (TSB) levels before, during the phototherapy on a covered definite spot of skin and after 2 days of post-phototherapy in preterm and term newborns.
Materials and methods: A total of 272 babies, who had jaundice, admitted to NICU of Sahota Superspeciality Hospital, Kashipur, Uttarakhand, India, were enrolled in the study during the period March 2018 to February 2020. TCB and TSB were done in all the babies and compared before starting phototherapy, during phototherapy, and after 48 hours of stopping the phototherapy.
Results: Before phototherapy (PT)-TCB showed statistically significant positive correlation with before PT-TSB. During PT-TCB showed statistically significant positive correlation with PT-TSB. After PT-TCB showed statistically significant positive correlation. Bilirubin level measured by TCB and TSB method was statistically significantly comparable before, during, and after PT (p > 0.05).
Conclusion: There is significant positive correlation between TCB and TSB in preterm and term newborns who required phototherapy for hyperbilirubinemia, before starting the phototherapy, during phototherapy, and after 48 hours of its stoppage.
Clinical significance: Transcutaneous bilirubin is a good tool to do screening for hyperbilirubinemia. TCB can be used as a noninvasive tool to assess bilirubin during and after phototherapy.
Key scientific associations: newborn, neonate, hyperbilirubinemia, infant, bilirubin encephalopathy, kernicterus, athetoid cerebral palsy, high-frequency hearing loss, intellectual disability, transcutaneous bilirubinometers, phototherapy units, neo blue light, wavelength,
irradiance.
-------------------------------------------------------------------------------------------------------------------------------------------------------------
Hameed NN, Khaleel MM, Saugstad OD. Timely Respiratory Support Can Improve Clinical Outcomes of Premature Infants in a Country with Limited Medical Resources due to Chronic Conflicts. Newborn 2024; 3(1):13-18. DOI: 10.5005/jp-journals-11002-0088.
Abstract: Introduction: The children of Iraq have suffered greatly from military conflicts and economic sanctions since 1991. Recent years have shown some improvement in neonatal and infant mortality but more efforts are needed; prematurity and associated respiratory distress syndrome (RDS) remain the two leading causes. In this study, we investigated the efficiency of timely institution of nasal continuous positive airway pressure (nCPAP) in stabilizing these infants. These data are needed for the optimum allocation of financial resources to improve the healthcare outcomes of infants.
Patients and methods: This prospective cross-sectional study was carried out over 6 months from April 1st to September 30th, 2022. Inborn preterm infants born between 26 and 32+0 weeks’ gestation who required respiratory support after delivery or immediately after admission were included. The data for the initial course of respiratory support and outcomes were assessed.
Results: In our cohort of 123 infants, nCPAP significantly increased the likelihood of clinical stabilization in infants with a gestational age (GA) >28 weeks (p = 0.022), birth weight (BW) ≥1500 gm (p = 0.016), use of antenatal steroids (p = 0.002), Apgar score at 5 minutes of life (p = 0.022), mild radiographic findings (p = 0.007), and sepsis without prolonged rupture of membranes (p = 0.027). Nasal continuous positive airway pressure also reduced the need for surfactant (p = 0.001) and mortality (p = 0.0001).
Conclusion: Early institution of nCPAP improved the respiratory status of premature infants who were born at a gestational age from >28 to ≤32 weeks, had birth weight ≥1500 gm, had received antenatal steroids, had a 5-minute Apgar score >7, and had sepsis but no PROM. The success of early nCPAP reduced the need for surfactant and mechanical ventilation, risk of pulmonary hemorrhage, and mortality.
Key scientific associations: Baby, Infant, armed conflicts, high-risk war zones, INSURE, Mechanical ventilation, Minimal invasive surfactant therapy, Neonatology, Neonate, Neonatal intensive care unit, Newborn, Preterm infants, Respiratory distress syndrome, Gulf War, perinatal mortality, social safety, international conventions, skilled birth attendants, European Consensus Guidelines, surfactant bolus, less invasive surfactant administration (LISA), minimally invasive surfactant technique (MIST), synchronized intermittent mandatory ventilation, assist/control ventilation, pressure support ventilation, tachypnea, dyspnea, supplementary oxygen, New Ballard score, granularity of lungs, pneumothorax, antenatal steroids.
------------------------------------------------------------------------------------------------------------------------------------------------------
Maheshwari A, Mantry H, Bagga N, Frydrysiak-Brzozowska A, Badarch J, Rahman MM. Milk Fat Globules: 2024 Updates. Newborn 2024; 3(1):19–37. DOI: 10.5005/jp-journals-11002-0085.
Abstract: Milk fat globules (MFGs) are a remarkable example of nature’s ingenuity. Human milk (HM) carries contains 3–5% fat, 0.8–0.9% protein, 6.9–7.2% carbohydrate calculated as lactose, and 0.2% mineral constituents. Most of these nutrients are carried in these MFGs, which are composed of an energy-rich triacylglycerol (TAG) core surrounded by a triple membrane structure. The membrane contains polar lipids, specialized proteins, glycoproteins, and cholesterol. Each of these bioactive components serves important nutritional, immunological, neurological, and digestive functions. These MFGs are designed to release energy rapidly in the upper gastrointestinal tract and then persist for some time in the gut lumen so that the protective bioactive molecules are conveyed to the colon. These properties may shape the microbial colonization and innate immune properties of the developing gastrointestinal tract. Milk fat globules in milk from humans and ruminants may resemble in structure but there are considerable differences in size, profile, composition, and specific constituents. There are possibilities to not only enhance the nutritional composition in a goal-oriented fashion to correct specific deficiencies in the infant but also to use these fat globules as a nutraceutical in infants who require specific treatments. To mention a few, there might be possibilities in enhancing neurodevelopment, in defense against gastrointestinal and respiratory tract infections, improving insulin sensitivity, treating chronic inflammation, and altering plasma lipids. This review provides an overview of the composition, structure, and biological activities of the various components of the MFGs. We have assimilated research findings from our own laboratory with an extensive review of the literature utilizing key terms in multiple databases including PubMed, EMBASE, and Science Direct. To avoid bias in the identification of studies, keywords were short-listed a priori from anecdotal experience and PubMed’s Medical Subject Heading (MeSH) thesaurus.
Key scientific associations: 1,4-β-N-acetylmuraminidase, Absorbable sphingosine, Acetyl-CoA carboxylase 1, Acyl-CoA synthetase, Acyl-CoA synthetase long chain family member 3, Acyl-CoA synthetase long chain family member 5, Adipophilin, Adipose differentiation-related proteins, ADPF, Alpha-1-antitrypsin, Annexin, Apocrine-like glands, Apolipoprotein A1, Apolipoprotein A-IV, Apolipoprotein C-III, Apolipoprotein E, Apolipoproteins, Arachidonic acid, Arginine-glycine-aspartate (RGD), Bacteroidetes, Bayley Scales of Infant and Toddler Development II, Bifidobacterium, Bile salt-stimulated lipase, Bone marrow stromal antigen 2, C16-ceramide, C18:0, C24-ceramide, Casein micelles, Cathelicidins, C-C motif chemokine ligand 2, CD9 antigen, Ceramidase, Ceramide, Ceramide-1-phosphate, Cerebrosides, Chlorella vulgaris, Cholesterol, Choline, Chordin-like protein 2,Clusterin, Complement C3, Conjugated linoleic acid, Coriobacteriaceae, De Brouckère mean diameter, Dermcidin, Desulfovibrionaceae, Diacylglycerol acyltransferase 1, Disialylated gangliosides, Docosahexaenoic acid, Elongase, Endoplasmic reticulum Enterobacteriaceae, Enterococcaceae, Erysipelotrichaceae, Exosomes, FA-binding protein, Factor V/VIII domain containing, Fagan test of infant intelligence, Fatty acid desaturase, Fatty acid synthase, Fatty acid-binding protein, Firmicutes, Folate receptor alpha, Food matrix, Free-play sustained attention test of Colombo, Gamma-glutamyltranspeptidase 1, Gangliosides, GD3, Gelsolin, Glutathione peroxidase 3, Glycam1, Glycan adhesion factors, Glycerol-3-phosphate acyltransferase 4, Glycobiome, Glycogen synthase kinase-3 β, Glycoproteins, Glycosphingolipids, Glycerol-3-phosphate acyltransferase 4, Glycogen synthase kinase-3 beta, Glycosylation-dependent cell adhesion molecule 1, Glycosylation-dependent cell adhesion molecule-1, GM3 Heat shock protein beta-1, Hormone-sensitive lipase, Human leukocyte antigen II, IgA α-chain, Insulin-like growth factor binding protein 2, Isobutyric acid, Isovaleric acid, Kyoto Encyclopedia of Genes and Genomes, Lactadherin, Lactating mammary gland packages, Lactobacillus, Lactobacillus rhamnosus GG, Lactoferrin, Lactophorin, Lactosome, Lanosterol synthase, Large-size MFG, Linoleic, Lipid rafts, Lipid-ordered microdomains, Lipoprotein lipase, Long-chain FA-CoA ligase, Lysophosphatidic acid acyltransferase, Lysozyme, Lysozyme C, MARCKS-related proteinapolipoprotein D, Mastitis, Matrilin-3, MFG epidermal growth factor 8, MFGE8 Microfiltration, Milk fat globule EGF, Milk fat globules, Monocyte differentiation CD14, Mucin 4, Mucins, Mycoplasma agalactiae, NAD(P) dependent steroid dehydrogenase-like, Nannochloropsis gaditana, Neutral glycosphingolipids, Nonspecific lipid transfer protein, Number-weighted mean, O-lined glycan, Pasteurization, Per-Arnt-Sim (PAS) domain 6/7, Perilipin, Perilipin 2, Peroxisomal acyl-coenzyme A oxidase 3, Peroxisomal bifunctional enzyme, Peroxisomal multifunctional enzyme type 2, Phosphatidylcholine, Phosphatidylethanolamine, Phosphatidylinositol, Phosphatidylserine, Phospholipids, PL/TAG, Plasmalogens, Polar lipids, Porphyromonadaceae, Proactivator polypeptide, Proteobacteria, Proteose peptone component 3, Rikenellaceae, Salmonella enteritides, Sauter mean diameter, Small MFGs, Soluble N-ethylmaleimide–sensitive fusion attachment protein receptor, Sphingoids, Sphingolipid, Sphingolipids, Sphingomyelin, Sphingomyelin phosphodiesterase, Sphingophospholipids, Sphingosine, Sphingosine-1-phosphate, Spirulina platensis, Staphylococcus aureus, Triacylglycerol core, Tail-interacting protein-47, Tenascin, Toll-like receptor 2, Triacylglycerol, Triassic period, Ubiquitin, V/VIII like domains, Visual evoked potential latencies, Xanthine oxidoreductase, α-amylase, α-linolenic acid, αvβ3 integrin receptors, αvβ5 integrin receptors, β-casein, ζ-potential, ω-3 polyunsaturated fatty acids, ω-3 PUFA, ω-6 PUFA.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Guaragni B, Motta M. Hemostasis Assessment in Neonates: Evaluation of Viscoelastic Properties of Blood Clots. Newborn 2024; 3(1):38–44. DOI: 10.5005/jp-journals-11002-0089.
Abstract: In recent years, a new approach to neonatal hemostasis has been taking hold. The term “developmental hemostasis” refers to the dynamic, age-related physiological changes seen in the hemostatic system in neonates and young infants. Most conventional coagulation tests have limitations as these are focused primarily on the procoagulant factors and do not inform about platelet function and the levels/activity of von Willebrand factor (vWF), natural anticoagulants, and fibrinolytic activity. In this scheme, viscoelastic coagulation tests can rapidly provide a potentially useful, panoramic assessment of the entire coagulation process from the formation to degradation of clots, platelet function, and fibrinolysis. This is a narrative review on the use of viscoelastic tests in neonatal care; we have included information from our own clinical experience and from an extensive literature search spanning PubMed, Scopus, and Web of Science. This review is important because tests can help identify premature/critically ill infants who may be at risk of hemorrhage during routine care or after surgery and may need corrective transfusions with appropriate blood products.
Key scientific associations: Activated partial prothrombin time, activated partial thromboplastin time, prothrombin time, developmental hemostasis, fibrinogen levels, fibrinolytic activity, natural anticoagulants, platelet function, procoagulant factors, prothrombin time, Viscoelastic coagulation tests, von Willebrand factor, thromboelastography, thromboelastometry, clotting, coagulation process, clot degradation, platelet function, fibrinolysis, rotating activator, fibrin strand, rotational thromboelastometry, vitamin K-dependent coagulation factors, protein C, protein S, viscoelastic coagulation tests, viscoelastic coagulation monitor (VCM) device, Clot kinetics, alpha angle, maximum clot firmness, fbrinolysis, LY30, LY60, congenital diaphragmatic hernia, DIC, ECMO, thrombin-initiated fibrin clot kinetic
assay, anti-FXa activity, neonatal bleeding risk (NeoBRis) index, factor VIII activity, TEG 5000, maximum thrombus generation (MRTG) rate.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------
Maheshwari A, Huisman TAGM. Holoprosencephaly. Newborn 2024; 3(1):45-60. DOI: 10.5005/jp-journals-11002-0083.
Abstract: Holoprosencephaly (HPE) is a complex malformation of the forebrain resulting from failed or incomplete division of the forebrain during the embryonic period. It is the most frequently seen developmental abnormality of the forebrain in humans; the incidence is nearly 1 of every 250 human embryos. However, most of these embryos do not survive and are lost to miscarriage. At birth, the prevalence is 1 in 8,000–10,000 live births and stillbirths. In HPE, the cleavage of the forebrain (prosencephalon) into the right and left hemispheres, deep brain structures, and the olfactory and optic bulbs and tracts remains incomplete. These central nervous system (CNS) defects develop during the first few 2–3 weeks of the fetal period. The etiopathogenesis is unclear, although both syndromic and isolated HPE can be heritable. The condition involves multiple systems, including the central nervous system, eyes, hearing, olfactory, gastrointestinal system, and genital tracts can be most severely affected. No specific treatment is known. Careful clinical and genetic evaluation is necessary for symptomatic management and for counseling families. In this article, we present our own clinical and imaging experience and combine it with an extensive search in the databases PubMed, EMBASE, and Scopus. To avoid bias, keywords were identified from discussions in our own group and from PubMed’s Medical Subject Heading (MeSH) thesaurus.
Key scientific associations: 7-dehydrocholesterol reductase, Alobar, Ambiguous genitalia, Anophthalmia, Arhinencephaly, Asegmentation, pseudotrisomy 13; genoa syndrome (semilobal hpe); and brachial amelia, Azygos anterior cerebral artery, Butterfly sign, Caudal dysgenesis, Cavum septi pellucidi, Ccr4-not transcription complex, Cell adhesion associated, Cell adhesion molecule-related/downregulated by oncogenes, Cerebellar hypoplasia, Chiari I malformation, Chromosomal errors, Circle of Willis, Cleft lip, Cripto, Culler–Jones syndrome, de Morsier syndrome, Delta-like canonical notch ligand 1, Demyer, Dispatched RND transporter family member, Dispatched RND transporter family member 1, EGF-CFC family member, Fibroblast growth factor 8, Fibroblast growth factor 8 (FGF8), Fibroblast growth factor receptor 1, Fibroblast growth factor receptor 1 (FGFR1), Forebrain, Forkhead BOX H1 FOXH1, Forkhead box protein h1, Frenulum, Frontonasal dysplasia, GLI family zinc finger 2, Growth arrest specific 1, Growth arrest specific 1 (GAS1), Hartsfield syndrome, Holoventricle, Hypothalamic hamartoblastomata, Infant, Lysine methyltransferase 2d, Lysine methyltransferase 2d (KMT2d), Malformation, Meckel syndrome, Median cleft face syndrome, Microform, Microphthalmia, Microtia-anotia, Middle interhemispheric fusion variant, Midline cleft syndrome, Monoventricle, Neonate, Newborn, Nodal growth differentiation factor, Nodal growth differentiation factor (NODAL), Olfactory bulb, Oncogene regulated, Optic bulb, Pallister–Hall syndrome, Patched 1, Patched 1 (PTCH1), Pathogenic copy number variations, Polydactyly, Prokineticin receptor, Prosencephalon, Protein patched homolog, Protein patched homolog 1 (PTCH1), Protein phosphatase 1 regulatory subunit 12a, Protein phosphatase 1 regulatory subunit 12a (PPP1R12a), Rad21 cohesin complex component, Rubinstein–Taybi syndrome, Semilobar, Septo-optic dysplasia (SOD), Septo-preoptic, SHH mutations, Sine oculis homeobox homolog, Sine oculis homeobox homolog 3, Single maxillary central incisor, Smith-Lemli-Opitz, Smith-Lemli-Opitz syndrome, Snake under the skull, Solitary median maxillary central incisor, Sonic hedgehog, Stag2 cohesin complex component, STIL centriolar assembly protein, Structural maintenance of chromosomes 1a, Structural maintenance of chromosomes 3, Subunit 1, Sufu negative regulator of hedgehog signaling, Sylvian fissures, Syntelencephaly, TGF-beta-induced factor homeobox factor 1, Trisomy 13, Yim–Ebbin syndrome, ZIC2 mutations, Zinc finger protein, Zinc finger protein ZIC2.
----------------------------------------------------------------------------------------------------------------------------------------------------------------
Maheshwari A, Singh S, Sharma V, Subramanian PG, Garg AS. Many Term infants with Persistent Patency of the Ductus Arteriosus could be Trisomy 21 Mosaics. Newborn 2024; 3(1):61–64. DOI: 10.5005/jp-journals-11002-0090.
Abstract: We report findings from a term infant with persistent patency of the ductus arteriosus (PDA). His fetal tests had shown some ambiguity for trisomy 21. However, he did not show any of the frequently-seen phenotypic features associated with trisomy 21 in utero or after birth, and the postnatal karyotype was reported as normal. One of our team members decided to request for a repeat karyotype and he was then identified as a mosaic for this aneuploidy. These observations are potentially important because the proportion of affected cells could very well be a determinant of the phenotypic variability seen in infants with Down syndrome. Hence, mosaicism might need to be meticulously excluded in patients who are presented with only one or more phenotypic features associated with trisomy 21. In this report, we have briefly reviewed the need for evaluation in such infants; the diagnosis requires specific evaluation of in-vitro cultured blood lymphocytes from the patients, siblings, and parents for somatic and germinal trisomy 21 mosaicism. The mechanisms underlying the origin of trisomy 21 mosaicism are still unclear; embryonic meiotic errors such as nondisjunction and anaphase lag, and subsequent mitotic malsegregation may be responsible. Uniparental disomy needs investigation. In the absence of somatic recombination, postzygotic malsegregation in an originally unaffected, disomy 21 zygote could also be a cause. The incidence of this condition in the community might be higher than hitherto believed.
Key scientific associations: Anaphase lag, copy-number alteration, fluorescence in situ hybridization, germinal trisomy 21 mosaicism, high-grade mosaics, infant, meiotic errors, mitotic malsegregation, newborn, neonate, nondisjunction, postzygotic malsegregation, sSomatic trisomy 21 mosaicism, hematopoietic system, next-generation sequencing.
A composite PDF file containing all the articles in volume 3, issue 1; January-March 2024 is provided here. The references (with links) to all the individual articles are listed below:
©2024 Global Newborn Society, "Every Baby Counts"